BIOCRYST SCHEDULED TO PRESENT AT THE SG COWEN SECURITIES 24TH ANNUAL HEALTHCARE CONFERENCE

March 5, 2004
BIOCRYST SCHEDULED TO PRESENT AT THE SG COWEN SECURITIES 24TH ANNUAL HEALTHCARE CONFERENCEBirmingham, Alabama - March 5, 2004 - BioCryst Pharmaceuticals, Inc. (Nasdaq NM: BCRX) announced that Charles E. Bugg, Ph.D., Chairman and CEO, will be presenting at the SG Cowen Securities 24th Annual Healthcare Conference in Boston on Wednesday, March 10, 2004, at 2:15 p.m. Eastern Standard Time. Interested investors can listen to the presentation live over the Internet during the conference at the following address:

What: BioCryst Pharmaceuticals, Inc. Presentation at the SG Cowen Securities 24th Annual Healthcare Conference

When: Wednesday, March 10, 2004, at 2:15 p.m. EST

Where: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=BCRX&item_id=851980

How: Live over the Internet -- Simply log on to the web at the address above

For those unable to listen at the designated time, the webcast will remain available for replay on http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=BCRX&item_id=851980 for 90 days following the conference.

Founded in 1986, BioCryst Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of small-molecule pharmaceuticals to treat cancer, cardiovascular and autoimmune diseases, and viral infections.